Annual Total Assets
$9.03 M
-$7.37 M-44.91%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual total assets is $9.03 million, with the most recent change of -$7.37 million (-44.91%) on December 1, 2023.
- During the last 3 years, NBY annual total assets has fallen by -$6.20 million (-40.71%).
- NBY annual total assets is now -62.32% below its all-time high of $23.98 million, reached on December 31, 2021.
Performance
NBY Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$3.88 M
-$48.00 K-1.22%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly total assets is $3.88 million, with the most recent change of -$48.00 thousand (-1.22%) on September 1, 2024.
- Over the past year, NBY quarterly total assets has dropped by -$8.97 million (-69.83%).
- NBY quarterly total assets is now -84.36% below its all-time high of $24.79 million, reached on March 31, 2022.
Performance
NBY Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
NBY Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.9% | -69.8% |
| 3 y3 years | -40.7% | -75.8% |
| 5 y5 years | -3.5% | -75.8% |
NBY Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.3% | at low | -84.4% | at low |
| 5 y | 5-year | -62.3% | at low | -84.4% | at low |
| alltime | all time | -62.3% | +587.0% | -84.4% | +8.8% |
NovaBay Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.88 M(-1.2%) |
| Jun 2024 | - | $3.92 M(-26.7%) |
| Mar 2024 | - | $5.36 M(-40.7%) |
| Dec 2023 | $9.03 M(-44.9%) | $9.03 M(-29.7%) |
| Sep 2023 | - | $12.85 M(-19.7%) |
| Jun 2023 | - | $16.01 M(+8.0%) |
| Mar 2023 | - | $14.82 M(-9.6%) |
| Dec 2022 | $16.40 M(-31.6%) | $16.40 M(-26.7%) |
| Sep 2022 | - | $22.38 M(+3.9%) |
| Jun 2022 | - | $21.54 M(-13.1%) |
| Mar 2022 | - | $24.79 M(+3.4%) |
| Dec 2021 | $23.98 M(+57.4%) | $23.98 M(+95.9%) |
| Sep 2021 | - | $12.24 M(-10.0%) |
| Jun 2021 | - | $13.60 M(-3.3%) |
| Mar 2021 | - | $14.07 M(-7.7%) |
| Dec 2020 | $15.24 M(+35.8%) | $15.24 M(-10.8%) |
| Sep 2020 | - | $17.08 M(+28.7%) |
| Jun 2020 | - | $13.27 M(+40.1%) |
| Mar 2020 | - | $9.47 M(-15.6%) |
| Dec 2019 | $11.22 M(+19.9%) | $11.22 M(-23.2%) |
| Sep 2019 | - | $14.60 M(+48.0%) |
| Jun 2019 | - | $9.87 M(+1.5%) |
| Mar 2019 | - | $9.72 M(+3.8%) |
| Dec 2018 | $9.36 M(-7.1%) | $9.36 M(-9.7%) |
| Sep 2018 | - | $10.37 M(-11.4%) |
| Jun 2018 | - | $11.71 M(-15.3%) |
| Mar 2018 | - | $13.82 M(+37.1%) |
| Dec 2017 | $10.08 M(-34.5%) | $10.08 M(-8.8%) |
| Sep 2017 | - | $11.06 M(-8.4%) |
| Jun 2017 | - | $12.07 M(-4.8%) |
| Mar 2017 | - | $12.68 M(-17.5%) |
| Dec 2016 | $15.38 M(+203.0%) | $15.38 M(+1.6%) |
| Sep 2016 | - | $15.14 M(+116.1%) |
| Jun 2016 | - | $7.00 M(+42.1%) |
| Mar 2016 | - | $4.93 M(-2.9%) |
| Dec 2015 | $5.08 M | $5.08 M(-24.1%) |
| Sep 2015 | - | $6.69 M(-34.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $10.17 M(+24.8%) |
| Mar 2015 | - | $8.15 M(+8.2%) |
| Dec 2014 | $7.54 M(-51.8%) | $7.54 M(-31.7%) |
| Sep 2014 | - | $11.04 M(-18.3%) |
| Jun 2014 | - | $13.51 M(-21.4%) |
| Mar 2014 | - | $17.18 M(+9.8%) |
| Dec 2013 | $15.65 M(-18.6%) | $15.65 M(+27.8%) |
| Sep 2013 | - | $12.24 M(-4.5%) |
| Jun 2013 | - | $12.83 M(-16.8%) |
| Mar 2013 | - | $15.42 M(-19.9%) |
| Dec 2012 | $19.23 M(+20.5%) | $19.23 M(+40.7%) |
| Sep 2012 | - | $13.67 M(+13.2%) |
| Jun 2012 | - | $12.07 M(-14.0%) |
| Mar 2012 | - | $14.04 M(-12.0%) |
| Dec 2011 | $15.96 M(+2.9%) | $15.96 M(-12.8%) |
| Sep 2011 | - | $18.30 M(+21.7%) |
| Jun 2011 | - | $15.04 M(+2.5%) |
| Mar 2011 | - | $14.67 M(-5.5%) |
| Dec 2010 | $15.52 M(-11.5%) | $15.52 M(+18.3%) |
| Sep 2010 | - | $13.11 M(-4.1%) |
| Jun 2010 | - | $13.67 M(-15.4%) |
| Mar 2010 | - | $16.17 M(-7.7%) |
| Dec 2009 | $17.52 M(+25.4%) | $17.52 M(+15.0%) |
| Sep 2009 | - | $15.24 M(+17.0%) |
| Jun 2009 | - | $13.03 M(-12.9%) |
| Mar 2009 | - | $14.96 M(+7.1%) |
| Dec 2008 | $13.97 M(-41.6%) | $13.97 M(-19.8%) |
| Sep 2008 | - | $17.42 M(-8.9%) |
| Jun 2008 | - | $19.13 M(-14.1%) |
| Mar 2008 | - | $22.27 M(-6.9%) |
| Dec 2007 | $23.92 M(+101.6%) | $23.92 M(+193.3%) |
| Sep 2007 | - | $8.16 M(-12.5%) |
| Jun 2007 | - | $9.32 M(-18.8%) |
| Mar 2007 | - | $11.48 M(-3.2%) |
| Dec 2006 | $11.87 M(+233.1%) | $11.87 M(+233.1%) |
| Dec 2005 | $3.56 M(+170.9%) | $3.56 M |
| Dec 2003 | $1.31 M | - |
FAQ
- What is NovaBay Pharmaceuticals annual total assets?
- What is the all time high annual total assets for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual total assets year-on-year change?
- What is NovaBay Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly total assets year-on-year change?
What is NovaBay Pharmaceuticals annual total assets?
The current annual total assets of NBY is $9.03 M
What is the all time high annual total assets for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual total assets is $23.98 M
What is NovaBay Pharmaceuticals annual total assets year-on-year change?
Over the past year, NBY annual total assets has changed by -$7.37 M (-44.91%)
What is NovaBay Pharmaceuticals quarterly total assets?
The current quarterly total assets of NBY is $3.88 M
What is the all time high quarterly total assets for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly total assets is $24.79 M
What is NovaBay Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, NBY quarterly total assets has changed by -$8.97 M (-69.83%)